Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment
==============================================================================================================================================================================================================================================================

* Brenda C O'Connell
* Charley Hubbard
* Nora Zizlsperger
* Donna Fitzgerald
* Jeffrey L Kutok
* Judith Varner
* Robert Ilaria, Jr
* Melody A Cobleigh
* Dejan Juric
* Kate H R Tkaczuk
* Anthony Elias
* Arielle Lee
* Shaker Dakhil
* Erika Hamilton
* Hatem Soliman
* Stephane Peluso